BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 19460257)

  • 1. Classifying the severity of COPD: are the new severity scales better than the old?
    Esteban C; Quintana JM; Egurrola M; Moraza J; Aburto M; Pérez-Izquierdo J; Basualdo LV; Capelastegui A
    Int J Tuberc Lung Dis; 2009 Jun; 13(6):783-90. PubMed ID: 19460257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life is associated with COPD severity: a comparison between the GOLD staging and the BODE index.
    Medinas Amorós M; Mas-Tous C; Renom-Sotorra F; Rubí-Ponseti M; Centeno-Flores MJ; Gorriz-Dolz MT
    Chron Respir Dis; 2009; 6(2):75-80. PubMed ID: 19411567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of chronic obstructive pulmonary disease according to BTS, ERS, GOLD and ATS criteria in relation to doctor's diagnosis, symptoms, age, gender, and smoking habits.
    Lindberg A; Jonsson AC; Rönmark E; Lundgren R; Larsson LG; Lundbäck B
    Respiration; 2005; 72(5):471-9. PubMed ID: 16210885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of hospitalisations for exacerbations of COPD on health-related quality of life.
    Esteban C; Quintana JM; Moraza J; Aburto M; Egurrola M; España PP; Pérez-Izquierdo J; Aguirre U; Aizpiri S; Capelastegui A
    Respir Med; 2009 Aug; 103(8):1201-8. PubMed ID: 19272762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bronchial obstruction reversibility test in the assessment of COPD severity--controversies].
    Maskey-Warzechowska M; Pankowska M; Chazan R
    Pneumonol Alergol Pol; 2006; 74(1):68-71. PubMed ID: 17175980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Stage and prognosis of COPD].
    Akashiba T
    Nihon Rinsho; 2003 Dec; 61(12):2089-93. PubMed ID: 14674315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The new ATS/ERS guidelines for assessing the spirometric severity of restrictive lung disease differ from previous standards.
    Aggarwal AN; Agarwal R
    Respirology; 2007 Sep; 12(5):759-62. PubMed ID: 17875068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking Report from the Obstructive Lung Disease in Northern Sweden Studies.
    Lindberg A; Bjerg A; Rönmark E; Larsson LG; Lundbäck B
    Respir Med; 2006 Feb; 100(2):264-72. PubMed ID: 15975774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of health-related quality of life measurements using a single value in patients with asthma and chronic obstructive pulmonary disease.
    Nishimura K; Oga T; Ikeda A; Hajiro T; Tsukino M; Koyama H
    J Asthma; 2008 Sep; 45(7):615-20. PubMed ID: 18773337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction.
    Swanney MP; Ruppel G; Enright PL; Pedersen OF; Crapo RO; Miller MR; Jensen RL; Falaschetti E; Schouten JP; Hankinson JL; Stocks J; Quanjer PH
    Thorax; 2008 Dec; 63(12):1046-51. PubMed ID: 18786983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Obstructive Lung Disease in Northern Sweden Chronic Obstructive Pulmonary Disease Study: design, the first year participation and mortality.
    Lindberg A; Lundbäck B
    Clin Respir J; 2008 Oct; 2 Suppl 1():64-71. PubMed ID: 20298352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there any correlation between the ATS, BTS, ERS and GOLD COPD's severity scales and the frequency of hospital admissions?
    Tsoumakidou M; Tzanakis N; Voulgaraki O; Mitrouska I; Chrysofakis G; Samiou M; Siafakas NM
    Respir Med; 2004 Feb; 98(2):178-83. PubMed ID: 14971883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using post-bronchodilator FEV₁ is better than pre-bronchodilator FEV₁ in evaluation of COPD severity.
    Chen CZ; Ou CY; Wang WL; Lee CH; Lin CC; Chang HY; Hsiue TR
    COPD; 2012 Jun; 9(3):276-80. PubMed ID: 22360379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical practice guidelines for chronic obstructive pulmonary disease: a review and comparison of current resources.
    Pierson DJ
    Respir Care; 2006 Mar; 51(3):277-88. PubMed ID: 16533418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The importance of the at risk COPD patients (Stage 0) and clinical differences].
    Kömüs N; Tertemiz KC; Sevinç C
    Tuberk Toraks; 2008; 56(4):382-9. PubMed ID: 19123073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical utility of the GOLD classification of COPD disease severity in pulmonary rehabilitation.
    Huijsmans RJ; de Haan A; ten Hacken NN; Straver RV; van't Hul AJ
    Respir Med; 2008 Jan; 102(1):162-71. PubMed ID: 17881207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the Infectious Diseases Society of America/American Thoracic Society criteria to predict severe community-acquired pneumonia caused by Streptococcus pneumoniae.
    Kontou P; Kuti JL; Nicolau DP
    Am J Emerg Med; 2009 Oct; 27(8):968-74. PubMed ID: 19857416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early detection and impaired quality of life in COPD GOLD stage 0: a pilot study.
    Maleki-Yazdi MR; Lewczuk CK; Haddon JM; Choudry N; Ryan N
    COPD; 2007 Dec; 4(4):313-20. PubMed ID: 18027158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation between quality of life and morbidity and mortality in COPD patients: Two-year follow-up study.
    Yorgancioglu A; Havlucu Y; Celik P; Dinc G; Saka A
    COPD; 2010 Aug; 7(4):248-53. PubMed ID: 20673033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-related quality of life is related to COPD disease severity.
    Ståhl E; Lindberg A; Jansson SA; Rönmark E; Svensson K; Andersson F; Löfdahl CG; Lundbäck B
    Health Qual Life Outcomes; 2005 Sep; 3():56. PubMed ID: 16153294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.